Sai Life Sciences Ltd

Sai Life Sciences' Q2 FY26 results are strong, with a net profit of ₹83.84 crores (up 101.98% year-on-year) and revenue growth of 35.88%. While operational performance is solid, the return on equity remains low at 8.71%, indicating room for improvement.

Sai Life experienced significant financial growth from March 2024 to March 2025, with net sales rising to 1,694.57 Cr and profit after tax increasing to 170.13 Cr. The company improved its operating profit margin to 23.94% and reduced total debt from 710.16 Cr to 128.64 Cr.

Sai Life Sciences' latest results show mixed performance, with a net profit decline of 31.51% despite a 77.47% year-on-year revenue growth. While the balance sheet is strong and the company has eliminated long-term debt, it faces challenges in maintaining profitability due to rising operational costs and declining margins.

Sai Life's financial performance from March 2024 to March 2025 showed significant growth, with net sales increasing to 1,694.57 crore and profit after tax nearly doubling to 170.13 crore. The company improved its operating profit margin to 23.94% and eliminated long-term borrowings, indicating a stronger financial position.

As of 24-Sep, Sai Life Sciences Ltd's stock price is 890.95, down 0.12%. Despite a recent decline, the company shows strong fundamentals and year-to-date growth of 18.60%, although it faces downward pressure from broader market trends and reduced investor participation.

As of 23-Sep, Sai Life Sciences Ltd is currently priced at Rs 892.30, reflecting a 2.07% increase. Despite a slight monthly decline, the stock has strong year-to-date growth and solid financial health, supported by high institutional holdings.

As of 22-Sep, Sai Life Sciences Ltd's stock price is Rs 873.00, down 3.94%, underperforming its sector. Despite recent declines, the company has strong fundamentals and a positive year-to-date performance of 16.21%.

As of 19-Sep, Sai Life Sciences Ltd is currently priced at 900.05, reflecting a 0.65% increase, with strong financial health and significant institutional holdings. The stock has outperformed the market recently, indicating a positive outlook despite a slight decline in delivery volume.

As of 18-Sep, Sai Life Sciences Ltd is priced at 894.20, down 0.65%, having recently reversed a seven-day gain streak. Despite this short-term decline, the company shows strong fundamentals and year-to-date growth of 19.03%, indicating potential for long-term growth despite recent underperformance against its sector.

As of 17-Sep, Sai Life Sciences Ltd is currently priced at 900.05, reflecting a 2.06% increase and strong recent performance, outperforming its sector. Positive financial results and increased institutional holdings indicate strong fundamentals supporting the stock's upward momentum.

As of 16-Sep, Sai Life Sciences Ltd is priced at 881.90, having gained 3.27% over the last six days and outperforming the Sensex. Strong financial metrics, positive quarterly results, and increased investor interest are driving the stock's upward momentum.

As of 15-Sep, Sai Life Sciences Ltd's stock price is 881.05, up 1.21%, with a strong performance over the past week and year-to-date. The company shows significant growth in net sales and operating profit, alongside a favorable debt ratio and high institutional holdings, indicating a positive outlook.

As of 12-Sep, Sai Life Sciences Ltd is priced at 870.50, showing a recent increase and strong financial health, despite a decline in delivery volume. The stock has outperformed the Sensex year-to-date, indicating a positive long-term growth outlook.

As of 11-Sep, Sai Life Sciences Ltd's stock price is 868.55, up 0.56% today, with a year-to-date increase of 15.61%. Despite a recent decline in delivery volume and a monthly drop of 2.59%, the company shows strong financial health and outperforms the Sensex in the short term.

As of 10-Sep, Sai Life Sciences Ltd's stock price is 863.70, reflecting a 0.69% increase. The stock has shown strong performance with positive returns over the past week and month, despite a drop in delivery volume, supported by solid financial fundamentals and high institutional confidence.

As of 09-Sep, Sai Life Sciences Ltd is priced at 857.75, having increased by 0.44%. The stock has outperformed the Sensex recently, supported by strong financial health and high institutional holdings, indicating positive investor sentiment.

As of 08-Sep, Sai Life Sciences Ltd's stock price is at 854.00, down 0.3% after a trend reversal following three days of gains. Despite this decline, the stock has shown positive weekly and monthly returns, supported by strong fundamentals and high institutional holdings, although a significant drop in delivery volume may indicate changing investor sentiment.